162 related articles for article (PubMed ID: 21571686)
1. Multifaceted role of plasminogen activator inhibitor-1 in regulating early remodeling of vein bypass grafts.
Ji Y; Strawn TL; Grunz EA; Stevenson MJ; Lohman AW; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1781-7. PubMed ID: 21571686
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
3. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.
Ji Y; Fish PM; Strawn TL; Lohman AW; Wu J; Szalai AJ; Fay WP
J Thromb Haemost; 2014 Oct; 12(10):1667-77. PubMed ID: 25081365
[TBL] [Abstract][Full Text] [Related]
6. Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
Wu J; Peng L; McMahon GA; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1565-70. PubMed ID: 19574558
[TBL] [Abstract][Full Text] [Related]
7. Oral intake of hydrogen-rich water inhibits intimal hyperplasia in arterialized vein grafts in rats.
Sun Q; Kawamura T; Masutani K; Peng X; Sun Q; Stolz DB; Pribis JP; Billiar TR; Sun X; Bermudez CA; Toyoda Y; Nakao A
Cardiovasc Res; 2012 Apr; 94(1):144-53. PubMed ID: 22287575
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: effects on vascular smooth muscle cell differentiation and superoxide production.
West NE; Qian H; Guzik TJ; Black E; Cai S; George SE; Channon KM
Circulation; 2001 Sep; 104(13):1526-32. PubMed ID: 11571247
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1 and vitronectin protect against stenosis in a murine carotid artery ligation model.
de Waard V; Arkenbout EK; Carmeliet P; Lindner V; Pannekoek H
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1978-83. PubMed ID: 12482822
[TBL] [Abstract][Full Text] [Related]
10. Mature Vascular Smooth Muscle Cells, but Not Endothelial Cells, Serve as the Major Cellular Source of Intimal Hyperplasia in Vein Grafts.
Wu W; Wang C; Zang H; Qi L; Azhar M; Nagarkatti M; Nagarkatti P; Cai G; Weiser-Evans MCM; Cui T
Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1870-1890. PubMed ID: 32493169
[TBL] [Abstract][Full Text] [Related]
11. Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine carotid arteries.
Peng L; Bhatia N; Parker AC; Zhu Y; Fay WP
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):934-9. PubMed ID: 12067901
[TBL] [Abstract][Full Text] [Related]
12. The ADP antagonist MRS2179 regulates the phenotype of smooth muscle cells to limit intimal hyperplasia.
Liu R; Ma S; Lu Z; Shen H; Sun L; Wei M
Cardiovasc Drugs Ther; 2015 Feb; 29(1):23-9. PubMed ID: 25528944
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles Derived from Adipose Mesenchymal Stem Cells Regulate the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia.
Liu R; Shen H; Ma J; Sun L; Wei M
Cardiovasc Drugs Ther; 2016 Apr; 30(2):111-8. PubMed ID: 26650931
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of vein grafts: suppression of intimal hyperplasia of the vein graft but not the anastomosis.
LaMuraglia GM; Klyachkin ML; Adili F; Abbott WM
J Vasc Surg; 1995 Jun; 21(6):882-90; discussion 889-90. PubMed ID: 7776467
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of TGF-beta1-induced intimal growth: plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells.
Otsuka G; Stempien-Otero A; Frutkin AD; Dichek DA
Circ Res; 2007 May; 100(9):1300-7. PubMed ID: 17431190
[TBL] [Abstract][Full Text] [Related]
17. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
[TBL] [Abstract][Full Text] [Related]
18. Remodeling leads to distinctly more intimal hyperplasia in coronary than in infrainguinal vein grafts.
Zilla P; Moodley L; Scherman J; Krynauw H; Kortsmit J; Human P; Wolf MF; Franz T
J Vasc Surg; 2012 Jun; 55(6):1734-41. PubMed ID: 22386141
[TBL] [Abstract][Full Text] [Related]
19. Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts.
Diao Y; Guthrie S; Xia SL; Ouyang X; Zhang L; Xue J; Lee P; Grant M; Scott E; Segal MS
Am J Pathol; 2008 Mar; 172(3):839-48. PubMed ID: 18276778
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia.
Soleimani B; Katopodis A; Wieczorek G; George AJ; Hornick PI; Heusser C
Clin Exp Immunol; 2006 Dec; 146(3):509-17. PubMed ID: 17100772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
